CONTEXT: Disparities in cancer care for rural residents and for African Americans have been documented, but the interaction of these factors is not well understood. PURPOSE: The authors examined the simultaneous influence of race and place of residence on access to and utilization of specialized cancer care in the United States. METHODS: Access to specialized cancer care was measured using: (1) travel time to National Cancer Institute (NCI) Cancer Centers, academic medical centers, and any oncologist for the entire continental US population, and (2) per capita availability of oncologists for the entire United States. Utilization was measured as attendance at NCI Cancer Centers, specialized hospitals, and other hospitals in the Surveillance, Epidemiology, and End Results (SEER) program Medicare population from 1998-2004. FINDINGS: In urban settings, travel times were shorter for African Americans compared with Caucasians for all three cancer care settings, but they were longer for rural African Americans traveling to NCI Cancer Centers. Per capita oncologist availability was not significantly different by race or place of residence. Urban African American patients were almost 70% more likely to attend an NCI Cancer Center than urban Caucasian patients (OR = 1.66; 95% CI 1.51-1.83), whereas rural African American patients were 58% less likely to attend an NCI Cancer Center than rural Caucasian patients (OR = 0.42; 95% CI 0.26-0.66). CONCLUSIONS: Urban African Americans have similar or better access to specialized cancer care than urban Caucasians, but rural African Americans have relatively poor access and lower utilization compared with all other groups.
CONTEXT: Disparities in cancer care for rural residents and for African Americans have been documented, but the interaction of these factors is not well understood. PURPOSE: The authors examined the simultaneous influence of race and place of residence on access to and utilization of specialized cancer care in the United States. METHODS: Access to specialized cancer care was measured using: (1) travel time to National Cancer Institute (NCI) Cancer Centers, academic medical centers, and any oncologist for the entire continental US population, and (2) per capita availability of oncologists for the entire United States. Utilization was measured as attendance at NCI Cancer Centers, specialized hospitals, and other hospitals in the Surveillance, Epidemiology, and End Results (SEER) program Medicare population from 1998-2004. FINDINGS: In urban settings, travel times were shorter for African Americans compared with Caucasians for all three cancer care settings, but they were longer for rural African Americans traveling to NCI Cancer Centers. Per capita oncologist availability was not significantly different by race or place of residence. Urban African American patients were almost 70% more likely to attend an NCI Cancer Center than urban Caucasian patients (OR = 1.66; 95% CI 1.51-1.83), whereas rural African American patients were 58% less likely to attend an NCI Cancer Center than rural Caucasian patients (OR = 0.42; 95% CI 0.26-0.66). CONCLUSIONS: Urban African Americans have similar or better access to specialized cancer care than urban Caucasians, but rural African Americans have relatively poor access and lower utilization compared with all other groups.
Authors: Jenine K Harris; Julianne Cyr; Bobbi J Carothers; Nancy B Mueller; Victoria V Anwuri; Aimee I James Journal: Am J Public Health Date: 2011-05-12 Impact factor: 9.308
Authors: Michelle S Wong; David T Grande; Nandita Mitra; Archana Radhakrishnan; Charles C Branas; Katelyn R Ward; Craig E Pollack Journal: Med Care Date: 2017-09 Impact factor: 2.983
Authors: Kelsey L Besse; Jaime M Preussler; Elizabeth A Murphy; Ellen M Denzen; Michael C Lill; Jeffrey W Chell; Mary K Senneka; Navneet S Majhail; Eric P Williams Journal: J Oncol Pract Date: 2015-03 Impact factor: 3.840
Authors: Alexis P Chidi; Cindy L Bryce; Larissa Myaskovsky; Michael J Fine; David A Geller; Douglas P Landsittel; Allan Tsung Journal: Ann Surg Date: 2016-02 Impact factor: 12.969
Authors: Chun Chieh Lin; Suanna S Bruinooge; M Kelsey Kirkwood; Dawn L Hershman; Ahmedin Jemal; B Ashleigh Guadagnolo; James B Yu; Shane Hopkins; Michael Goldstein; Dean Bajorin; Sharon H Giordano; Michael Kosty; Anna Arnone; Amy Hanley; Stephanie Stevens; Christine Olsen Journal: Int J Radiat Oncol Biol Phys Date: 2015-12-17 Impact factor: 7.038
Authors: Georgiana Onicescu; Andrew Lawson; Jiajia Zhang; Mulugeta Gebregziabher; Kristin Wallace; Jan M Eberth Journal: Stat Methods Med Res Date: 2015-07-28 Impact factor: 3.021
Authors: Chun Chieh Lin; Suanna S Bruinooge; M Kelsey Kirkwood; Christine Olsen; Ahmedin Jemal; Dean Bajorin; Sharon H Giordano; Michael Goldstein; B Ashleigh Guadagnolo; Michael Kosty; Shane Hopkins; James B Yu; Anna Arnone; Amy Hanley; Stephanie Stevens; Dawn L Hershman Journal: J Clin Oncol Date: 2015-08-24 Impact factor: 44.544
Authors: Nader N Massarweh; Yi-Ju Chiang; Yan Xing; George J Chang; Alex B Haynes; Y Nancy You; Barry W Feig; Janice N Cormier Journal: J Clin Oncol Date: 2014-02-10 Impact factor: 44.544
Authors: Tracy Onega; Rebecca Hubbard; Deirdre Hill; Christoph I Lee; Jennifer S Haas; Heather A Carlos; Jennifer Alford-Teaster; Andy Bogart; Wendy B DeMartini; Karla Kerlikowske; Beth A Virnig; Diana S M Buist; Louise Henderson; Anna N A Tosteson Journal: J Am Coll Radiol Date: 2014-06-02 Impact factor: 5.532